|
Jul 18, 2012, 06.38 PM IST
Pharma major Dr Reddy's Laboratories today announced that it has launched Atorvastatin calcium tablets, a bioequivalent generic version of Lipitor tablets in the US market.
The launch was followed by the approval by the United States Food & Drug Administration (USFDA) of Dr Reddy's ANDA for atorvastatin calcium tablets, a company statement said here. The Lipitor brand had US sales of approximately USD 8.07 billion for the most recent twelve months ending March 2012 according to IMS Health. Dr Reddy's Atorvastatin calcium tablets are available in bottle count sizes of 90 and 500, the release said.
Related News Set email alert for |
Action in Dr Reddys Laboratories
 From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'  The latest earning numbers FIRST on CNBC-TV18
News Videos
|
